Impact of recently initiated medications on the incidence of urinary tract infections in patients with type 2 diabetes: an observational case-control study.

ABSTRACT:

Background

Patients with type 2 diabetes (T2DM) are at risk of developing urinary tract infections (UTIs). Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a common medication associated with UTIs in these patients. However, emerging data show that other medications may be more frequently prescribed prior to UTI diagnosis.

Objectives

Explore the correlation of newly prescribed medications in patients with the diagnosis of T2DM prior to an incidence of UTI and compare it to those without a UTI.

Design

This observational case-control study aimed to explore the correlation between the incidence of UTIs in patients with T2DM and new prescription medication fills.

Methods

Data were retrieved from national prescription and medical claims database IQVIA PharMetr

SUBMITTER: Hill JB 

PROVIDER: S-EPMC12712311 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature